{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T06:22:08Z","timestamp":1785046928411,"version":"3.55.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1093\/rheumatology\/kev429","type":"journal-article","created":{"date-parts":[[2016,2,14]],"date-time":"2016-02-14T18:34:26Z","timestamp":1455474866000},"page":"1556-1565","source":"Crossref","is-referenced-by-count":38,"title":["Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers"],"prefix":"10.1093","volume":"55","author":[{"given":"Lianne","family":"Kearsley-Fleet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Baildam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Beresford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taunton R.","family":"Southwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimme L.","family":"Hyrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,1,4]]},"reference":[{"key":"2016082300521506000_55.9.1556.1","first-page":"1975","article-title":"Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register","volume":"23","author":"Symmons","year":"1996","journal-title":"J Rheumatol"},{"key":"2016082300521506000_55.9.1556.2","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"2016082300521506000_55.9.1556.3","unstructured":"European Medicines Agency\/Committee for Medicinal Products for Human Use. Enbrel. Summary of opinion (post authorisation). 2012. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000262\/human_med_000764.jsp&mid=WC0b01ac058001d124 (5 May 2015, date last accessed)."},{"key":"2016082300521506000_55.9.1556.4","unstructured":"National Institute for Health and Care Excellence. Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis. 2002. https:\/\/www.nice.org.uk\/guidance\/ta35 (1 December 2015, date last accessed)."},{"key":"2016082300521506000_55.9.1556.5","unstructured":"National Institute for Health and Care Excellence. Tocilizumab for the treatment of systemic juvenile idiopathic arthritis. 2011. https:\/\/www.nice.org.uk\/Guidance\/TA238 (30 November 2015, date last accessed)."},{"key":"2016082300521506000_55.9.1556.6","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/annrheumdis-2013-204641","article-title":"Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register","volume":"74","author":"Otten","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2016082300521506000_55.9.1556.7","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-011-1720-7"},{"key":"2016082300521506000_55.9.1556.8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken492"},{"key":"2016082300521506000_55.9.1556.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112802"},{"key":"2016082300521506000_55.9.1556.10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.134254"},{"key":"2016082300521506000_55.9.1556.11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.12703\/P6-21","article-title":"Treatment advances in systemic juvenile idiopathic arthritis","volume":"6","author":"Beukelman","year":"2014","journal-title":"F1000prime Rep"},{"key":"2016082300521506000_55.9.1556.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205099"},{"key":"2016082300521506000_55.9.1556.13","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-15-14"},{"key":"2016082300521506000_55.9.1556.14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/bcp.12406","article-title":"The development and assessment of biological treatments for children","volume":"79","author":"Smith","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"2016082300521506000_55.9.1556.15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201060"},{"key":"2016082300521506000_55.9.1556.16","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R"},{"key":"2016082300521506000_55.9.1556.17","doi-asserted-by":"publisher","DOI":"10.1002\/art.38296"},{"key":"2016082300521506000_55.9.1556.18","doi-asserted-by":"publisher","DOI":"10.1002\/art.10885"},{"key":"2016082300521506000_55.9.1556.19","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2012.3"},{"key":"2016082300521506000_55.9.1556.20","first-page":"615","article-title":"A case of macrophage activation syndrome successfully treated with anakinra. Nature clinical practice","volume":"4","author":"Kelly","year":"2008","journal-title":"Rheumatology"},{"key":"2016082300521506000_55.9.1556.21","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e318205092d"},{"key":"2016082300521506000_55.9.1556.22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq218"},{"key":"2016082300521506000_55.9.1556.23","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket170"},{"key":"2016082300521506000_55.9.1556.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.01.005"},{"key":"2016082300521506000_55.9.1556.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2005.01062.x"},{"key":"2016082300521506000_55.9.1556.26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel030"},{"key":"2016082300521506000_55.9.1556.27","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.058248"},{"key":"2016082300521506000_55.9.1556.28","doi-asserted-by":"publisher","DOI":"10.1002\/art.20904"},{"key":"2016082300521506000_55.9.1556.29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq308"},{"key":"2016082300521506000_55.9.1556.30","doi-asserted-by":"crossref","unstructured":"Garcia-De-Vicuna C Diaz-Llopis M Salom D . Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis. Mediators Inflamm 2013;2013:560632.","DOI":"10.1155\/2013\/560632"},{"key":"2016082300521506000_55.9.1556.31","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2147\/OPTH.S23646","article-title":"Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis","volume":"5","author":"Kotaniemi","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"2016082300521506000_55.9.1556.32","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.12218"},{"key":"2016082300521506000_55.9.1556.33","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem356"},{"key":"2016082300521506000_55.9.1556.34","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-013-2275-x"},{"key":"2016082300521506000_55.9.1556.35","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2013.735657"},{"key":"2016082300521506000_55.9.1556.36","unstructured":"ClinicalTrials.gov. Effect of adalimumab for the treatment of uveitis in juvenile idiopathic arthritis (ADJUVITE). 2015. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01385826 (27 October 2015, date last accessed)."},{"key":"2016082300521506000_55.9.1556.37","doi-asserted-by":"publisher","DOI":"10.1002\/art.38454"},{"key":"2016082300521506000_55.9.1556.38","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.126532"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T11:35:53Z","timestamp":1567596953000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-lookup\/doi\/10.1093\/rheumatology\/kev429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,4]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,8,23]]},"published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1093\/rheumatology\/kev429"],"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kev429","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,4]]}}}